Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTPase-activating protein GIT1 (GIT1) is a multidomain enzyme belonging to the ArfGAP protein family, primarily functioning as a GTPase-activating protein (GAP) for ADP-ribosylation factor (Arf) small GTPases, notably ARF6[1][2][4]. In addition to its enzymatic activity, GIT1 acts as a scaffolding protein integrating signals from small GTPase and protein kinase pathways and facilitating interactions between proteins such as PIX, PAK, paxillin, and MEK[1][2][4]. GIT1 is involved in the regulation of cytoskeletal dynamics, cell migration, endocytosis, and synaptic development, localizing to focal adhesions and endocytic structures[1][2][4]. Dysregulation or altered expression of GIT1 has been implicated in several pathological processes, including cancer progression (via MEK/ERK signaling scaffolding and effects on proliferation/metastasis), cardiovascular disease (via signal transduction and cytoskeletal regulation), and neurodevelopmental disorders[1][2][4]. GIT1 contains several conserved domains, including an N-terminal zinc finger ArfGAP domain, ankyrin repeats, a Spa2-homology domain (SHD), coiled-coil domain, and a carboxyl-terminal region that interacts with paxillin[1][2][4]. As of now, no clinically approved drugs are known to interact directly with GIT1, but it remains a research target in oncology and neurobiology[1][2][4].
Inhibition/modulation of ARF GTPase pathway through GAP activity; Modulation of protein–protein interaction networks involved in cell migration and signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTPase-activating protein GIT1 (GIT1).